IL1B and colitis: In a mouse model of DSS-induced colitis, intraperitoneal administration of ADM was shown to inhibit colon inflammation, and research has shown that administration of ADM reduces the levels of cytokines such as TNF-α, IL-1β, and IL-6 [22].